Clinical promise of next-generation complement therapeutics

DC Mastellos, D Ricklin, JD Lambris - Nature reviews Drug discovery, 2019 - nature.com
The complement system plays a key role in pathogen immunosurveillance and tissue
homeostasis. However, subversion of its tight regulatory control can fuel a vicious cycle of …

C3 glomerulopathy—understanding a rare complement-driven renal disease

RJH Smith, GB Appel, AM Blom, HT Cook… - Nature reviews …, 2019 - nature.com
The C3 glomerulopathies are a group of rare kidney diseases characterized by complement
dysregulation occurring in the fluid phase and in the glomerular microenvironment, which …

KDIGO 2021 clinical practice guideline for the management of glomerular diseases

BH Rovin, SG Adler, J Barratt, F Bridoux… - Kidney …, 2021 - kidney-international.org
Glomerular disease, be it primary or secondary, occurring in the setting of systemic
autoimmune diseases, infections, drugs, or malignancy, affects individuals of all ages. In …

[HTML][HTML] Atypical hemolytic uremic syndrome and C3 glomerulopathy: conclusions from a “Kidney Disease: Improving Global Outcomes”(KDIGO) Controversies …

THJ Goodship, HT Cook, F Fakhouri, FC Fervenza… - Kidney international, 2017 - Elsevier
In both atypical hemolytic uremic syndrome (aHUS) and C3 glomerulopathy (C3G)
complement plays a primary role in disease pathogenesis. Herein we report the outcome of …

Complement in disease: a defence system turning offensive

D Ricklin, ES Reis, JD Lambris - Nature Reviews Nephrology, 2016 - nature.com
Although the complement system is primarily perceived as a host defence system, a more
versatile, yet potentially more harmful side of this innate immune pathway as an …

[HTML][HTML] Diagnosis of monoclonal gammopathy of renal significance

F Bridoux, N Leung, CA Hutchison, G Touchard… - Kidney international, 2015 - Elsevier
Monoclonal gammopathy of renal significance (MGRS) regroups all renal disorders caused
by a monoclonal immunoglobulin (MIg) secreted by a nonmalignant B-cell clone. By …

Current understanding of the role of complement in IgA nephropathy

N Maillard, RJ Wyatt, BA Julian, K Kiryluk… - Journal of the …, 2015 - journals.lww.com
Complement activation has a role in the pathogenesis of IgA nephropathy, an autoimmune
disease mediated by pathogenic immune complexes consisting of galactose-deficient IgA1 …

Mayo clinic/renal pathology society consensus report on pathologic classification, diagnosis, and reporting of GN

S Sethi, M Haas, GS Markowitz… - Journal of the …, 2016 - journals.lww.com
Renal pathologists and nephrologists met on February 20, 2015 to establish an
etiology/pathogenesis-based system for classification and diagnosis of GN, with a major aim …

Immunosuppressive medications

AC Wiseman - Clinical Journal of the American Society of …, 2016 - journals.lww.com
Immunosuppressive agents are commonly used in the nephrologist's practice in the
treatment of autoimmune and immune-mediated diseases and transplantation, and they are …

Dynamics of complement activation in aHUS and how to monitor eculizumab therapy

M Noris, M Galbusera, S Gastoldi… - Blood, The Journal …, 2014 - ashpublications.org
Atypical hemolytic-uremic syndrome (aHUS) is associated with genetic complement
abnormalities/anti–complement factor H antibodies, which paved the way to treatment with …